• Company
• EUSA Pharma establishes subsidary in Korea
• by Eo, Yun-Ho Feb 8, 2022 05:55am

• Product
• Defective tablets of Lipitor were found
• by Kim JiEun Feb 8, 2022 05:54am

• Company
• Entresto's outpatient prescriptions exceed ₩30 billion
• by Feb 8, 2022 05:54am

• Policy
• HPV vaccine expanded free vaccination for men and women
• by Lee, Jeong-Hwan Feb 8, 2022 05:54am

• Policy
• Generics for Bridion are being released one after another
• by Lee, Tak-Sun Feb 7, 2022 05:58am

• Company
• Celltrion begins global P3T for its inhaled COVID-19 therapy
• by Ji Yong Jun Feb 7, 2022 05:57am

• Policy
• 1 ‘Soliris’ and 4 ‘Ultomiris’ cases seek prior approval
• by Lee, Hye-Kyung Feb 7, 2022 05:57am

• Company
• Hugel's Letybo has been approved in France
• by Feb 7, 2022 05:57am

• Company
• Samsung BioLogics acquired ₩2.8 trillion stake in Epis
• by Ji Yong Jun Feb 7, 2022 05:57am

• Product
• Actinum is a troublemaker?
• by Kim JiEun Feb 7, 2022 05:57am